InvestorsHub Logo
Followers 95
Posts 2738
Boards Moderated 0
Alias Born 09/15/2020

Re: newman2021 post# 543350

Sunday, 12/04/2022 2:06:42 PM

Sunday, December 04, 2022 2:06:42 PM

Post# of 694958
You can find the same arguments in that story like:

"There are better treatments coming in the future". Our UK friends main argument

"The trial will never get approved by FDA" . Our good friends Ex, The Dr and Hygro

A letter written to the FDA by a panelist from their advisory panel, who neglected he had a conflict of interest, which was not true. Our other UK friend Matt Williams, who wrote the comment on the JAMA article.

I am not even referring to the naked short aspect of Dendreon stocks, as I am not convinced that it is the same. It could be now that they might need some naked shorts to keep the price down, but without the options market and with a chance of uplisting on the horizon, this might not be in their current arsenal. The legal shorts might actually wish for uplisting, so they can engage in a more widespread shorting.

There's hundreds of these similarities in this story.

Charities with deep conflict of interests, like the two charities mentioned in a previous post.

Simply an amazing story and a must read for EVERY investor in NWBO. My jaw is still dragging on the floor from the similarities. I wish I would have read this story years ago. I would still have been invested in NWBO, but I would have been trading the stock like crazy. Now with the new lawsuit, that trading part is likely gone.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News